FORA Capital LLC Purchases Shares of 37,630 Option Care Health, Inc. (NASDAQ:OPCH)

FORA Capital LLC purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 37,630 shares of the company’s stock, valued at approximately $1,178,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after purchasing an additional 750 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its position in shares of Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after acquiring an additional 1,446 shares during the period. International Assets Investment Management LLC boosted its position in shares of Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after acquiring an additional 2,757 shares during the period. Finally, Blue Trust Inc. boosted its position in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The stock was purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. 0.64% of the stock is owned by insiders.

Option Care Health Price Performance

Shares of OPCH opened at $23.76 on Thursday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a 50 day simple moving average of $27.16 and a 200 day simple moving average of $28.96. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63. The firm has a market capitalization of $4.04 billion, a PE ratio of 19.97, a P/E/G ratio of 2.42 and a beta of 1.32.

Analysts Set New Price Targets

OPCH has been the subject of several research reports. JMP Securities increased their price objective on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Truist Financial lowered their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Barrington Research lowered their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Finally, The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.